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In Brief
Iyer-Bierhoff et al. show that reversible
acetylation of fibrillarin (FBL) regulates
methylation of histone H2A at glutamine
104 (H2AQ104) and controls rDNA
transcription. The study identifies a
mechanism underlying cell-cycle-
dependent fluctuations in H2AQ104
methylation and rRNA synthesis driven by
SIRT7-mediated deacetylation of FBL.
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Fibrillarin (FBL) is a dual-function nucleolar protein
that catalyzes 20-O methylation of pre-rRNA and
methylation of histone H2A at glutamine 104
(H2AQ104me). The mechanisms that regulate FBL
activity are unexplored. Here, we show that FBL is
acetylated at several lysine residues by the acetyl-
transferase CBP and deacetylated by SIRT7. While
reversible acetylation does not impact FBL-medi-
ated pre-rRNAmethylation, hyperacetylation impairs
the interaction of FBL with histone H2A and chro-
matin, thereby compromising H2AQ104 methylation
(H2AQ104me) and rDNA transcription. SIRT7-depen-
dent deacetylation of FBL ensures H2AQ104me
and high levels of rRNA synthesis during interphase.
At the onset of mitosis, nucleolar disassembly is
accompanied by hyperacetylation of FBL, loss of
H2AQ104me, and repression of polymerase I (Pol I)
transcription. Overexpression of an acetylation-defi-
cient, but not an acetylation-mimicking, FBL mutant
restores H2AQ104me and transcriptional activity.
The results reveal that SIRT7-dependent deacetyla-
tion impacts nucleolar activity by an FBL-driven cir-
cuitry thatmediates cell-cycle-dependent fluctuation
of rDNA transcription.INTRODUCTION
Acetylation of histones and regulatory proteins by lysine acetyl-
transferases (KATs) plays major roles in the regulation of gene
expression by linking cell signaling pathways to chromatin struc-
ture and transcriptional activity. Like many other protein modifi-
cations, acetylation is reversible. Mammalian lysine deacety-
lases (KDACs) are classified into three subgroups based on
sequence similarity and cofactor requirement. Class III KDACs,
the sirtuin family of protein deacetylases, require the cofactor
NAD+ for lysine deacetylation. The seven mammalian sirtuins,2946 Cell Reports 25, 2946–2954, December 11, 2018 ª 2018 The A
This is an open access article under the CC BY-NC-ND license (http://denoted SIRT1–SIRT7, have distinct cellular localizations and
target multiple substrates (Michishita et al., 2005). The nucleolar
member of the sirtuin family, SIRT7, stimulates transcription
of rRNA genes (rDNA) and ribosome biogenesis (Chen et al.,
2013; Ford et al., 2006). Previous work has established that
SIRT7 activates rDNA transcription by deacetylating polymer-
ase-associated factor 53 (PAF53), a subunit of mammalian
RNA polymerase I (Pol I) (Chen et al., 2013). SIRT7 also regulates
pre-rRNA processing by deacetylating U3-55k, a core compo-
nent of the U3 small nucleolar ribonucleoprotein (snoRNP) com-
plex (Chen et al., 2016). The role of SIRT7 in ribosome biogenesis
and cell proliferation is also supported by recent proteomic ana-
lyses showing that SIRT7 is associated with numerous proteins
that are involved in transcription, ribosome biogenesis, and
translation (Tsai et al., 2014; Blank et al., 2017). Among SIRT7-
associated proteins was fibrillarin (FBL), a conserved nucleolar
protein that is required for 20-O-methylation of pre-rRNA,
early cleavage steps, and ribosome assembly (Tollervey et al.,
1991, 1993; Tyc and Steitz, 1989). FBL is a component of
snoRNPs containing NOP56, NOP58, NHP2L1, and box C/D
small nucleolar RNAs (snoRNAs) that guide FBL to specific posi-
tions in rRNA. Some sites in rRNA are differentially methylated,
which may account for ribosome heterogeneity under certain
physiological conditions (Birkedal et al., 2015; Krogh et al.,
2016).
In addition to methylation of rRNA, FBL was found to meth-
ylate histone H2A at glutamine (Q) 104 in mammals, Q105 in
yeast, and Q106 in plants (Loza-Muller et al., 2015; Tessarz
et al., 2014). Glutamine methylation of histone H2A positively
correlates with Pol I transcription. How H2AQ104 methylation
is regulated, affects chromatin architecture, and is linked to
rDNA transcription is not known. FBL is acetylated at several
lysine residues (Choudhary et al., 2009; Scho¨lz et al., 2015), sug-
gesting that reversible acetylation regulates FBL activity. Here,
we show that FBL acetylation does not affect rRNA methylation
and pre-rRNA processing but attenuates FBL binding to histone
H2A and compromises Q104 methylation. Conversely, deacety-
lation by SIRT7 increases H2AQ104 methylation (H2AQ104me)
and enhances Pol I transcription. Acetylation-dependent regula-
tion of FBL activity links cell-cycle-dependent fluctuations of
Pol I transcription to H2AQ104me levels. At the onset of mitosis,uthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. SIRT7 Deacetylates FBL
(A) Immunoblots showing co-immunoprecipitation
of GFP-SIRT7 with FBL, NOP58, and TTF-I.
(B) Immunoblots showing co-immunoprecipita-
tion of endogenous SIRT7 with FBL and NOP58.
Asterisk indicates a heavy-chain immunoglobulin
G (IgG) band that migrates at 50 kDa.
(C) Western blot with pan-ac-K antibody showing
acetylation of Fl-FBL expressed in SIRT7+/+ and
SIRT7/ HEK293T cells in the absence or pres-
ence of hemagglutinin (HA)-tagged CBP.
(D) Acetylation of GFP-FBL from SIRT7+/+ and
SIRT7/ cells with or without NAM treatment
(10 mM, 5 hr).
(E) In vitro deacetylation assay of GFP-FBL from
SIRT7/ HEK293T cells using purified Fl-SIRT7.
(F) Western blot monitoring acetylation of wild-
type (WT) and mutant (4KR and 4KQ) FBL ex-
pressed in SIRT7+/+ or SIRT7/ cells. Note that
4KQ-FBL migrates slower than WT and 4KR-FBL.
FBL-ac/tagged FBL represents the ratio of acet-
ylated to total immunoprecipitated FBL normal-
ized to control (lane 1).
See also Figure S1.FBL is released from the nucleolus organizer regions (NORs) and
is distributed to the perichromosomal region (Dundr et al., 2000).
This relocalization prevents the interaction with SIRT7, which
leads to hyperacetylation of FBL, loss of H2AQ104me, and
establishment of a transcription-refractive chromatin structure.
At the exit from mitosis, deacetylation of FBL facilitates restora-
tion of H2AQ104me and resumption of rDNA transcription. The
results provide insights into the control of nucleolar activity
by a SIRT7- and FBL-driven circuitry that impacts H2AQ104
methylation and rDNA transcription.
RESULTS
SIRT7 Deacetylates FBL
To validate the association of SIRT7 with box C/D snoRNPs,
we monitored the interaction of SIRT7 with FBL and NOP58
by co-immunoprecipitation experiments. Consistent with mass
spectrometric data showing that SIRT7 interacts with box C/D
snoRNP components (Blank et al., 2017; Tsai et al., 2014), these
experiments revealed the association of SIRT7 with FBL and
NOP58, but not with the Pol I-specific transcription termination
factor TTF-I (Figures 1A, 1B, and S1A).
Previous acetylome analyses revealed that FBL is acetylated
at multiple lysine residues (Choudhary et al., 2009; Scho¨lz
et al., 2015). To identify the acetyltransferases that acetylate
FBL, we co-expressed GFP-tagged FBL with p300, CBP, or
PCAF and examined the acetylation state of GFP-FBL on west-
ern blots with an antibody that recognizes acetyl-lysine (ac-K).
While acetylation was hardly detectable in untransfected cells
and cells overexpressing p300 or PCAF, there was a clear signal
after overexpression of CBP (Figure S1B). In support of SIRT7
counteracting CBP-mediated acetylation of FBL, acetylationincreased 2-fold in the presence of nicotinamide (NAM), a spe-
cific inhibitor of NAD+-dependent sirtuins, whereas treatment
with trichostatin A (TSA), an inhibitor of class I and II deacety-
lases, did not alter FBL acetylation (Figure S1C).
To examine whether SIRT7 reverts CBP-mediated acetylation
of FBL, we compared the acetylation state of FBL isolated from
parental HEK293T cells (SIRT7+/+) and SIRT7/ cells in which
both SIRT7 alleles were inactivated by CRISPR (clustered regu-
larly interspaced short palindromic repeats)/Cas9-mediated
mutagenesis (Chen et al., 2016). In support of SIRT7 targeting
FBL, acetylation of FBL was higher in SIRT7/ cells than
SIRT7+/+ cells and was further augmented by overexpression
of CBP (Figure 1C). Conversely, overexpression of GFP-SIRT7
decreased FBL acetylation in SIRT7/ cells. (Figure S1D). FBL
acetylation inSIRT7/ cells was not further augmented by treat-
ment with NAM, indicating that SIRT7 is the major (if not only)
sirtuin that targets FBL (Figure 1D).
To demonstrate that SIRT7 deacetylates FBL, we performed
in vitro deacetylation assays using hyperacetylated GFP-FBL
from SIRT7/ cells. Acetylation of GFP-FBL was markedly
decreased in the presence of immunopurified SIRT7 and
NAD+, confirming that FBL is deacetylated by SIRT7 (Figure 1E).
Global acetylome studies have shown that FBL is acetylated at
four conserved lysine residues (K102, K121, K205, and K206)
(Choudhary et al., 2009; Scho¨lz et al., 2015) (Figure S1E). To
examine whether SIRT7 targets these lysine residues, we re-
placed them by either arginine (4KR) or glutamine (4KQ) to mimic
the hypo- or hyperacetylated state of FBL, respectively. While
acetylation of wild-type (WT) FBLwas 2.4-fold higher inSIRT7/
cells than SIRT7+/+ cells, acetylation of the 4KR- or 4KQ-FBL
mutants did not increase, substantiating that themutated lysines
are targeted by SIRT7 (Figure 1F).Cell Reports 25, 2946–2954, December 11, 2018 2947
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Figure 2. FBL Acetylation Inhibits Pre-rRNA Synthesis, but Not Methylation and Processing
(A) Immunostaining of 5-FUrd-labeled RNA in FBL-depleted U2OS cells expressing FLAG-taggedWT-, 4KR-, or 4KQ-FBL. Labeled RNA is stained with anti-BrdU
(green) and FBL (red). Scale bar, 10 mm. Quantification shows 5-FUrd staining as mean intensity per nucleus (n = 30–40 cells from three biological replicates).
Unpaired t test with Welch’s correction was applied. ***p% 0.001. See also Figure S2A.
(B) Northern blot of RNA from U2OS cells expressing WT or mutant FBL. The scheme on the left indicates rRNA processing intermediates hybridizing to the
radiolabeled ITS1 probe (orange). The ratio of 18SE to 30S rRNA is shown below. See also Figure S2A.
(C) CLIP-qRT-PCR monitoring pre-rRNA and snoRNA binding of Fl-FBL in SIRT7+/+ and SIRT7/ cells.
(D) ChIP-qPCR showing rDNA occupancy of Pol I and acetylated histone H4 (H4ac) in HEK293T cells transfected with control siRNAs or siRNAs targeting FBL,
SIRT7, or both. Data are shown as percentage of input, and H4ac is normalized to total histone H4. The position of amplicons is shown. See also Figures S2F
and S2G.
(E) FAIRE-qPCR showing chromatin accessibility of rDNA in control, FBL-, and SIRT7-depleted HEK293T cells. Data represent the ratio of extracted chromatin to
input.
Bars represent mean ± SEM; n = 3. *p% 0.05, **p% 0.01, n.s, nonsignificant.
See also Figure S2 and Table S2.FBL Acetylation Inhibits Pre-rRNA Synthesis, but Not
Methylation or Processing
To study the impact of FBL acetylation on pre-rRNA synthesis
and maturation, we depleted cells of FBL using small interfering
RNA (siRNA) that targets the 30 UTR of FBL mRNA and assayed
nucleolar transcription after overexpression of wild-type and
mutant FBL. After pulse-labeling with 5-fluorouridine (5-FUrd)
and immunostaining with anti-bromodeoxyuridine (anti-BrdU)
antibody, bright nucleolar signals were observed in control cells.2948 Cell Reports 25, 2946–2954, December 11, 2018There was hardly any nucleolar staining in FBL knockdown cells.
Overexpression of wild-type FBL or the acetylation-deficient
4KR mutant, but not the acetylation-mimetic 4KQ mutant,
restored pre-rRNA synthesis (Figures 2A and S2A). Overexpres-
sion of single or double K/Q mutants rescued transcription
similar to WT-FBL (Figure S2B). Recent mass spectrometric
analysis revealed that K102, K121, and K205 are hyperacety-
lated in SIRT7-deficient cells, substantiating that SIRT7 targets
several lysines in FBL.
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Figure 3. Acetylation of FBL Regulates Glutamine Methylation
(A) U2OS cells transfected with control siRNA or siRNAs against FBL or SIRT7 or both, were stained with antibodies against H2AQ104me (red) and UBF (green).
Scale bar, 10 mm.
(B) U2OS cells depleted of FBL by 30 UTR-targeting siRNA were transfected with plasmids encoding wild-type or mutant FBL. Cells were stained with anti-
H2AQ104me (red) and anti-FBL (green) antibodies. Scale bar, 10 mm. See Figure S3E for quantification.
(C) H2AQ104 methylation in control or SIRT7-depleted U2OS cells overexpressing FLAG-tagged WT-, 4KR-, or 4KQ-FBL. Cells were stained with anti-
H2AQ104me (red) and anti-FLAG antibodies (green). Scale bar, 10 mm. See also Figure S3F.
(D) H2AQ104me in control or SIRT7-depleted U2OS cells overexpressing TIF-IA-S649D. Cells were stained with anti-H2AQ104me (red) and anti-UBF (green)
antibodies. Scale bar, 10 mm. See also Figures S3G–S3I.
(E) ChIP-qPCR showing rDNA occupancy of FBL in control and SIRT7-depleted cells expressing Fl-TIF-IA-S649D. Percentage of input after subtraction of IgG
values is shown.
(F) qPCR showing rDNA occupancy of anti-FLAG ChIPs from mock-transfected HEK293T cells or cells expressing WT-, 4KR-, or 4KQ-FBL. Percentage of input
after subtraction of IgG values is shown. See also Figure S3J.
(legend continued on next page)
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To investigate the molecular mechanism by which acetylation
of FBL impairs Pol I transcription, we first examined whether
acetylation affects pre-rRNA processing. Northern blot analysis
using an ITS1 probe that detects rRNA processing intermediates
revealed accumulation of 30S rRNA at the expense of 21S and
18SE rRNA in FBL-deficient cells (Figure 2B). Both wild-type
FBL and the two mutants partially rescued the processing
defect, as seen by increased levels of 21S and 18SE processing
intermediates compared to FBL-depleted cells, indicating that
the acetylation state of FBL does not affect pre-rRNA process-
ing. Moreover, cross-linking immunoprecipitation (CLIP) experi-
ments revealed that hyperacetylated FBL from SIRT7/ cells
bound to rRNA and snoRNAs similarly as FBL from parental
SIRT7+/+ cells (Figure 2C). Thus, acetylation affects neither
pre-rRNA processing nor the interaction of FBL with RNA.
Given that FBL exerts a key function in 20-O ribosemethylation
(Kiss-La´szlo´ et al., 1996), we reasoned that acetylation might
regulate rRNA methylation. To test this, we subjected RNA
from SIRT7+/+ and SIRT7/ HEK293T cells to RiboMeth-seq,
a quantitative high-throughput method that interrogates RNA
ribose methylation based on protection from alkaline cleavage
by the 20-O-methyl (20-O-Me) group (Birkedal et al., 2015).
RiboMeth-seq profiles of RNA from SIRT7+/+ and SIRT7/
cells revealed only two minor differences in cytoplasmic RNA
(Figure S2C) and no differences in nuclear RNA (Figure S2D).
Depletion of SIRT7 by siRNAs also did not affect 20-O-Me (Fig-
ure S2E), indicating that FBL acetylation does not impact rRNA
methylation.
Knockdown of FBL, SIRT7, or both proteins decreased Pol I
occupancy at rDNA, while the association of UBF with rDNA re-
mained unaffected. The level of acetylated histone H4 (H4ac)
was also reduced, suggesting that FBL and SIRT7 contribute
to the establishment of a transcription-permissive chromatin
structure (Figures 2D, S2F, and S2G). This view is supported
by formaldehyde-assisted isolation of regulatory elements
(FAIRE) assays, which measure nucleosome density according
to chromatin extractability. Consistent with SIRT7-mediated de-
acetylation of FBL being conducive to transcription, the fraction
of extractable rDNA was significantly reduced in both FBL- and
SIRT7-depleted cells (Figure 2E). The intriguing correlations
among hypoacetylation of FBL, chromatin opening, Pol I recruit-
ment and rDNA transcription suggest that the acetylation state of
FBL plays a key role in chromatin-based processes that promote
Pol I transcription.
Acetylation Impairs the Interaction of FBL with Histone
H2A and Attenuates Glutamine Methylation
In addition to its established function in pre-rRNA methylation,
FBL is known to methylate nucleolar histone H2A at glutamine
104 (Tessarz et al., 2014). As acetylation of FBL impaired Pol I(G) Far-western blots with anti-His and anti-FLAG antibodies showing binding of
(H) Far-western blot showing binding of His-H2A to Fl-FBL immunopurified from
(I) Far-western blot showing binding of WT and mutant FBL to His-H2A. The ratio
(J) Untreated or NAM-treated U2OS cells were subjected to PLA with anti-FBL
Hoechst 33342 staining. Quantification shows number of PLA foci per nucleus (
correction was applied. ***p% 0.001. Scale bar, 10 mm. See also Figure S3M.
Bars represent mean ± SEM; n = 3. *p% 0.05, **p% 0.01.
2950 Cell Reports 25, 2946–2954, December 11, 2018transcription without affecting pre-rRNA processing and RNA
methylation, we reasoned that acetylation might regulate
FBL-directed histone methylation. Current batches of anti-
H2AQ104me antibody yield high background in chromatin im-
munoprecipitations (ChIPs) and western blots but reliably stain
nucleolar H2AQ104me.We thereforemonitored the link between
FBL acetylation and H2AQ104 methylation by quantitative
immunofluorescence. In accord with a previous study (Tessarz
et al., 2014), nucleolar staining of H2AQ104me was abolished
after knockdown of FBL. Knockdown of SIRT7 or double knock-
down of SIRT7 and FBL led to similar reduction in H2AQ104me,
indicating that SIRT7-mediated deacetylation of FBL promotes
H2AQ104 methylation (Figure 3A). Inhibition of H2AQ104me
and pre-rRNA synthesis in SIRT7-depleted cells was overcome
by expression of wild-type SIRT7, but not a catalytically inactive
SIRT7 mutant (SIRT7-H187Y), demonstrating that the enzymatic
activity of SIRT7 is required for H2A methylation and rDNA tran-
scription (Figures S3A–S3C). Inhibition of SIRT7 by nicotinamide
or overexpression of CBP attenuated the H2AQ104me signal,
reinforcing that hyperacetylation of FBL impairs H2AQ104
methylation (Figure S3D).
To validate the relevance of FBL acetylation in H2AQ104
methylation, we examined H2AQ104me after overexpression of
wild-type or mutant FBL in FBL-deficient cells. In accord with
FBLbeing required forH2AQ104me, knockdownofFBLabolished
H2AQ104me. While wild-type FBL and the 4KR mutant rescued
H2AQ104me, the 4KQ mutant did not promote H2AQ104me
(Figures3BandS3E). Strikingly,H2AQ104mewasalsoattenuated
by depletion of SIRT7. As in FBL-deficient cells, H2AQ104mewas
rescued by 4KR-FBL, but not 4KQ-FBL or wild-type FBL, which is
hyperacetylated in SIRT7-deficient cells (Figures 3C and S3F).
Together, these results reveal that SIRT7-mediated deacetylation
of FBL is required for H2AQ104 methylation.
To exclude that the decreased level of H2AQ104me is due
to secondary effects brought about by diminished pre-rRNA
synthesis in SIRT7-depleted cells, we monitored H2AQ104me
after augmenting Pol I transcription by overexpression of TIF-
IA-S649D, a constitutively active mutant of the Pol-I-specific
transcription initiation factor TIF-IA (Zhao et al., 2003). TIF-IA-
S649D enhanced rDNA transcription and Pol I binding in control
cells and also restored nucleolar transcription in SIRT7-depleted
cells (Figures S3G–S3I). H2AQ104me, however, remained low in
SIRT7-depleted cells, regardless whether or not Pol I transcrip-
tion was activated by TIF-IA-S649D (Figure 3D). Thus, increased
Pol I transcription alone is not sufficient to foster H2AQ104me
but requires deacetylation of FBL by SIRT7. The association of
FBL with rDNA was reduced in SIRT7-depleted cells, regardless
whether or not TIF-IA-S649D was overexpressed (Figure 3E).
Wild-type and the 4KR-FBL mutant efficiently bound to rDNA,
whereas binding of the acetylation-mimetic 4KQ-FBL mutantHis-tagged histones H2A and H1 to Fl-FBL. See also Figure S3K.
SIRT7+/+, SIRT7/ (top) or NAM-treated (bottom) HEK293T cells.
of H2A to FBL is normalized to WT (lane 1).
and anti-H2A antibodies. PLA signals are visualized as red foci and nuclei by
n = 50–60 cells from three biological replicates). Unpaired t test with Welch’s
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Figure 4. Hyperacetylation of FBL Attenuates H2AQ104me and rDNA Transcription during Mitosis
(A) Immunoblot showing co-immunoprecipitation of Fl-FBL and SIRT7 in asynchronous (AS) and nocodazole-arrested (100 ng/mL, 16 hr) mitotic (M) HEK293T
cells. See also Figure S4A.
(B) Acetylation of Fl-FBL from asynchronous (AS) or mitotic (M) HEK293T cells wasmonitored on immunoblots with anti-pan-ac-K antibody. See also Figure S4A.
(legend continued on next page)
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was significantly lower (Figures 3F and S3J). These results imply
that acetylation impairs binding of FBL to rDNA, which in turn
attenuates H2AQ104me.
To examinewhether reversible acetylation regulates binding of
FBL to histone H2A, we monitored the interaction of FBL with
histones by Far-western blot assays. Immunopurified FBL was
subjected to gel electrophoresis and transferred to a nitrocellu-
lose membrane, and binding of His-tagged H2A and H1 was
visualized onwestern blots. This assay revealed that FBL directly
and specifically interacts with histone H2A (Figures 3G and S3K).
Binding to histone H2A was compromised if FBL was purified
from SIRT7/ cells or from cells treated with NAM (Figure 3H).
Accordingly, wild-type FBL and the 4KR mutant bound H2A
more efficiently than 4KQ-FBL, corroborating that hypoacetyla-
tion promotes the interaction of FBL with H2A (Figure 3I). In
a complementary approach, we used immobilized His-tagged
histone H2A to pull down FBL from nuclear lysates. FBL from
control cells was efficiently pulled down by histone H2A. Inhibi-
tion of SIRT7 with nicotinamide decreased the FBL-H2A interac-
tion, underscoring the impact of SIRT7 activity on the association
of FBL with H2A (Figure S3L).
To examine the association of endogenous FBL with histone
H2A in vivo, we performed proximity ligation assays (PLA) using
anti-FBL and anti-H2A antibodies. Several bright nuclear foci
were visible in unperturbed cells, demonstrating the close prox-
imity (<40 nm) of FBL and histone H2A. Treatment with nicotin-
amide markedly reduced the PLA signal, supporting that acety-
lation impairs the interaction of FBL with H2A (Figures 3J and
S3M). While acetylation did not affect FBL binding to NOP58 or
snoRNAs (Figures S3N and 2C), knockdown of NOP58 led to
decreased levels of FBL, compromised rDNA transcription,
and diminished H2AQ104me (Figures S3O and S3P).
Hyperacetylation of FBL Attenuates H2AQ104me and
rDNA Transcription during Mitosis
As cells enter mitosis, nucleoli disassemble and Pol I tran-
scription is shut down (Heix et al., 1998). FBL is released from
rDNA, whereas SIRT7 and several components of the transcrip-
tion machinery remain associated with NORs (Ge´brane-Youne`s
et al., 1997; Grob et al., 2009; Sirri et al., 2000). The topological
separation of SIRT7 and FBL leads to hyperacetylation of FBL in
mitotic cells (Figures 4A, 4B, and S4A). Mitotic hyperacetylation
of FBL was not further augmented if SIRT7 activity was inhibited
by NAM (Figure 4C). The H2AQ104me signal was lost in prome-
taphase, coinciding with hyperacetylation of FBL (Figure S4B).
In control cells, the H2AQ104memark was reestablished in early
telophase, while in FBL- and SIRT7-depleted cells, H2AQ104me
remained low (Figures 4D and S4C).(C) Acetylation of Fl-FBL from untreated (Ctrl) or NAM-treated (10 mM, 5 hr) asyn
(D) Immunostaining of H2AQ104me (red) and UBF (green) in U2OS cells trans
counterstained with Hoechst 33342. Scale bar, 10 mm. See also Figure S4C.
(E) FBL-depleted U2OS cells expressingWT ormutant Fl-FBLwere immunostaine
telophase is shown below. Scale bar, 10 mm.
(F) Cells transfected as in (E) were labeled with 5-FUrd for 10min. Cells were staine
late telophase is shown below. Scale bar, 10 mm.
Quantification in (E) and (F) shows mean intensity per nucleus (n = 30–40 teloph
correction was applied. ***p% 0.001.
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correlated with fluctuations in pre-rRNA synthesis. Nucleolar
transcription was shut down at prophase and was resumed at
early telophase. After depletion of FBL or SIRT7, pre-rRNA syn-
thesis did not recommence at telophase (Figure S4D), under-
scoring the requirement of both SIRT7 and FBL in reactivation
of Pol I transcription at the exit from mitosis.
The impact of FBL deacetylation in the reestablishment of
H2AQ104me and resumption of Pol I transcription at telophase
was also shown by experiments monitoring the ability of ectopic
FBL to restore H2AQ104me and rDNA transcription in FBL-
depleted cells. Overexpression of wild-type FBL and 4KR-FBL
restored H2AQ104me and nucleolar transcription, while overex-
pression of 4KQ-FBL promoted neither H2AQ104 methylation
nor pre-rRNA synthesis in late telophase (Figures 4E and 4F).
Together, these results demonstrate that hyperacetylation of
FBL compromises H2AQ104 methylation and nucleolar tran-
scription at the onset of mitosis. At the exit from mitosis,
deacetylation of FBL by SIRT7 is required for deposition of
H2AQ104me and transcription activation.
DISCUSSION
Previous work has established that SIRT7 is associated
with rDNA and promotes cell growth and proliferation in
response to external cues (Ford et al., 2006). SIRT7 deacety-
lates PAF53, a subunit of mammalian Pol I, which facilitates
the association of Pol I with rDNA and augments transcription
(Chen et al., 2013). Moreover, SIRT7 regulates processing of
pre-rRNA by targeting and deacetylating U3-55k, which en-
hances its interaction with U3 snoRNA (Chen et al., 2016).
The role of SIRT7 in ribosome biogenesis and cell proliferation
has been highlighted by proteomic studies showing that SIRT7
is associated with numerous proteins with functions in tran-
scription, ribosome biogenesis, and translation (Blank et al.,
2017; Tsai et al., 2014). Among them was the nucleolar
protein FBL (yeast Nop1), the enzyme that methylates both
rRNA and nucleolar histone H2A. Given the importance of
SIRT7 and FBL in ribosome biogenesis (Tollervey et al.,
1991, 1993), we reasoned that SIRT7-dependent deacetyla-
tion of FBL might regulate 20-O-methylation and pre-
rRNA processing. Surprisingly, however, acetylation of FBL
affected neither methylation nor processing of pre-rRNA.
The RiboMeth-seq profiles in SIRT7+/+ and SIRT7/ cells
were almost identical, indicating that FBL acetylation has no
major impact on methylation of pre-rRNA.
We found that FBL acetylation regulates methylation of his-
tone H2A at Q104, a specific epigenomic mark that is dedicatedchronous (AS) or mitotic (M) cells.
fected with FBL- or SIRT7-targeting siRNAs and control siRNAs. DNA was
d for H2AQ104me (red) and FBL (green). Hoechst 33342 staining of nuclei in late
d with anti-BrdU (green) and anti-FBL (red). Hoechst 33342 staining of nuclei in
ase cells each from three biological replicates). Unpaired t test with Welch’s
to nucleolar transcription (Tessarz et al., 2014). In addition to
acetylation (Choudhary et al., 2009; Scho¨lz et al., 2015), FBL is
post-translationally modified by ubiquitylation (Kim et al., 2011)
and sumoylation (Hendriks et al., 2014). Replacement of four
acetylated lysine residues by arginine or glutamine, which
mimics the hypo- or hyperacetylated state of FBL, displayed
different abilities to rescue H2AQ104me and pre-rRNA synthesis
in FBL- or SIRT7-depleted cells. Thus, acetylation rather
than other modifications of FBL impact H2AQ104me and Pol I
transcription.
One could argue that reduced levels of H2AQ104me upon
SIRT7 depletion are a consequence of decreased transcription.
However, stimulation of Pol I transcription by overexpression of a
constitutively activemutant of the Pol I transcription factor TIF-IA
augmented neither FBL occupancy nor H2AQ104me levels,
demonstrating that H2AQ104 methylation is not a consequence
of enhanced transcription but requires deacetylation of FBL
by SIRT7. While acetylation did not affect the interaction
of FBL with pre-RNA, snoRNAs, or NOP58, acetylation abol-
ished the interaction of FBL with histone H2A and impaired
H2AQ104methylation. Likewise, depletion of NOP58 attenuated
H2AQ104me and pre-rRNA synthesis, indicating that FBL
assembled into snoRNPs methylates H2AQ104.
The mechanism that governs H2AQ104me-dependent activa-
tion of Pol I transcription remains elusive. The region of H2A
comprising Q104 has been shown to interact with FACT (facili-
tator of chromatin transcription), a conserved histone chaperone
that destabilizes H2A/H2B dimers. FACT promotes transcription
by disrupting nucleosomes and augmenting redeposition of nu-
cleosomes in the wake of elongating RNA polymerase (Orpha-
nides et al., 1998). Q104/5 resides in the ‘‘docking domain’’ at
the nexus between H2A/H2B and H3/H4 dimers, where methyl-
ation may cause conformational changes reminiscent of that in
H2A.Z, which contains a glycine at this position (Suto et al.,
2000). In support of hypoacetylated FBL promoting H2AQ104
methylation and chromatin decompaction, our ChIP and
FAIRE experiments show that depletion of FBL or SIRT7 leads
to decreased rDNA occupancy of Pol I, low levels of acetylated
histone H4, and chromatin compaction, indicating that
H2AQ104 methylation establishes a transcription-permissive
chromatin landscape. These results suggest that signaling
pathways that induce SIRT7-dependent FBL hypoacetylation
trigger H2AQ104 methylation and the establishment of a tran-
scription-permissive chromatin structure.
The importance of SIRT7-dependent deacetylation of FBL
on nucleolar transcription is most evident during cell-cycle
progression. Transcription of rDNA oscillates during the cell
cycle; it is maximal in S and G2 phases, repressed during
mitosis, and gradually recovers during G1 progression (Klein
and Grummt, 1999). Mitotic silencing of Pol I transcription
is caused by Cdk1-cyclin-B-dependent phosphorylation of
TAFI110, leading to impaired assembly of the promoter selec-
tivity factor SL1 and the Pol I transcription initiation complex
(Heix et al., 1998). Dephosphorylation of SL1 at the end of
mitosis relieves mitotic repression of Pol I transcription, indi-
cating that phosphorylation of the Pol I-specific TBP-TAF
complex is used as a molecular switch to shut off rDNA tran-
scription during mitosis.Here, we have uncovered an additional mechanism that regu-
lates rRNA synthesis during cell-cycle progression. We show
that the level of H2AQ104me is regulated by the dynamic interac-
tion between SIRT7 and FBL. At the onset of mitosis, release of
FBL to the chromosomal periphery is accompanied by hyper-
acetylation of FBL, loss of H2AQ104me and transcriptional shut-
down. At the exit from mitosis, SIRT7-dependent deacetylation
of FBL augments H2AQ104me and resumption of rRNA synthe-
sis. The intriguing link between FBL acetylation and H2AQ104
methylation suggests that reversible acetylation regulates
FBL-dependent H2AQ104me, which in turn facilitates efficient
Pol I transcription.
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit polyclonal anti-H2AQ104me (IF) Tessarz et al., 2014 N/A
Rabbit polyclonal anti-UBF (ChIP) Voit et al., 1999 N/A
Mouse monoclonal anti-UBF (IF) Santa Cruz Cat# sc-13125; RRID: AB_671403
Rabbit polyclonal anti-RPA116 (Pol I ChIP) Voit et al., 1999 N/A
Rabbit polyclonal anti-SIRT7 (WB and IP) Chen et al., 2016 N/A
Mouse monoclonal anti-FLAG (WB and IF) Sigma-Aldrich Cat# F3165; RRID: AB_259529
Rabbit polyclonal anti-GFP (WB) Abcam Cat# ab290; RRID: AB_303395
Mouse monoclonal anti-GFP (IF) Abcam Cat# ab1218; RRID: AB_298911
Monoclonal mouse anti-6X-His (WB) Abcam Cat# ab5000; RRID: AB_304722
Mouse monoclonal anti-BrdU (IF) Sigma-Aldrich Cat# B2531; RRID: AB_476793
Rabbit polyclonal anti-NOP58 (WB) Atlas antibodies Cat# HPA018472; RRID: AB_1854564
Rabbit polyclonal anti-histone H2A (WB) Millipore Cat# 07-146; RRID: AB_11212920
Rabbit polyclonal anti-histone H2A (PLA) Abcam Cat# ab88770; RRID: AB_10672053
Rabbit polyclonal anti-acetylated histone H4 (ChIP) Millipore Cat# 06-866; RRID: AB_310270
Rabbit polyclonal anti-histone H4 (ChIP) Active Motif Cat# 39269; RRID: AB_2636967
Rabbit polyclonal anti-histone H3 (WB) Diagenode Cat# C15310135
Rabbit polyclonal anti-acetyl-lysine (WB) Cell signaling Cat# 9441; RRID: AB_331805
Rabbit polyclonal anti-FBL (WB, IF and ChIP) Abcam Cat# ab5821; RRID: AB_2105785
Mouse monoclonal anti-FBL (IF and PLA) Abcam Cat# ab4566
Anti-rabbit HRP conjugate secondary antibody Jackson ImmunoResearch Labs Cat# 111-035-144; RRID: AB_2307391
Anti-mouse HRP conjugate secondary antibody Jackson ImmunoResearch Labs Cat# 115-035-062; RRID: AB_2338504
Goat anti-mouse Alexa Fluor 488 conjugate secondary antibody ThermoFisher Scientific Cat# A32723; RRID: AB_2633275
Goat anti-rabbit Cy3 conjugate secondary antibody Jackson ImmunoResearch Labs Cat# 111-165-144; RRID: AB_2338006
Bacterial and Virus Strains
Baculovirus encoding human FLAG-SIRT7 Chen et al., 2013 N/A
Chemicals, Peptides, and Recombinant Proteins
Nicotinamide (NAM) Sigma-Aldrich Cat# N3376
Trichostatin A (TSA) Cell Signaling Cat# 9950
Nicotinamide adenine dinucleotide (NAD+), Lithium salt Calbiochem Cat# 481915
Nocodazole Sigma-Aldrich Cat# M1404
Hoechst 33342 Sigma-Aldrich Cat# 14533
FLAG peptide Sigma-Aldrich Cat# F3290
His-tagged histone H1 Abcam Cat# ab206452
His-tagged histone H2A Abcam Cat# ab200295
Protein A-HRP ThermoFisher Scientific Cat# 101023
Critical Commercial Assays
TRI-Reagent Sigma-Aldrich Cat# T9424
M-MLV reverse transcriptase ThermoFisher Scientific Cat# 28025013
SuperScript IV reverse transcriptase ThermoFisher Scientific Cat# 18090010
Duolink Proximity ligation assay Sigma-Aldrich Cat# DUO92101
Muse Cell cycle assay kit Merck Millipore Cat# MCH100106
Lipofectamine 2000 ThermoFisher Scientific Cat# 11668019
Lipofectamine 3000 ThermoFisher Scientific Cat# L3000015
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Deposited Data
RiboMeth-seq NCBI Gene Expression Omnibus GSE115360
Experimental Models: Cell Lines
Human U2OS cell line ATCC HTB-96
Human HEK293T cell line ATCC CRL-11268
Oligonucleotides
Primers used in qPCR, see Table S1 This study N/A
Primers used for site-directed mutagenesis, see Table S1 This study N/A
Northern blot probe, see Table S1 Chen et al., 2016 N/A
Non-targeting ON-TARGETplus SMARTpool siRNAs Dharmacon Cat# D-001810-10
hSIRT7 ON-TARGETplus SMARTpool siRNAs Dharmacon Cat# L-007774-01
hFBL ON-TARGETplus SMARTpool siRNAs Dharmacon Cat# L-011269-00
Silencer Select siRNAs against the 30UTR of FBL mRNA ThermoFisher Scientific Cat# 4399665; (siRNA ID: s501803)
Silencer Select custom siRNAs against 30UTR of SIRT7
mRNA (Oligo 1)
ThermoFisher Scientific Cat# 4399665; (siRNA ID: s523487)
Silencer Select custom siRNAs against 30UTR of SIRT7
mRNA (Oligo 2)
ThermoFisher Scientific Cat# 4399665; (siRNA ID: s523488)
hNOP58 ON-TARGETplus siRNA Dharmacon Cat# J-017973-10
Recombinant DNA
Plasmid: pEGFP-C1 Clontech Cat# #6084-1
Plasmid: pCMV-Tag2a Stratagene Cat# 211172
Plasmid: pEGFP-C1-FBL This study N/A
Plasmid: pCMV-Tag2a-FLAG-FBL This study N/A
Plasmid: pEGFP-C1-SIRT7 Ford et al., 2006 N/A
Plasmid: pEGFP-C1-SIRT7-H187Y Ford et al., 2006 N/A
Plasmid: p300-HA Chen et al., 2013 N/A
Plasmid: HA-CBP Chen et al., 2013 N/A
Plasmid: FLAG-PCAF Chen et al., 2013 N/A
Plasmid: pFASTbac-FLAG-SIRT7 Chen et al., 2013 N/A
Plasmid: pcDNA-FLAG-TIF-IA-S649D Zhao et al., 2003 N/A
Software and Algorithms
CLUSTAL Omega https://www.ebi.ac.uk/Tools/
msa/clustalo
ImageJ https://imagej.nih.gov/ij/
Other
M2 anti-FLAG agarose resin Sigma-Aldrich Cat# A2220
GFP-Trap Chromotek Cat# gta-20CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents should be directed to and fulfilled by the Lead Contact, Dr. Ingrid Grummt (i.grummt@
dkfz.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
U2OS and HEK293T cells were purchased from ATCC (American Type Culture Collection) and grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% Fetal Bovine Serum (FBS) and 1% penicillin-streptomycin. Cells were maintained under standard
growth conditions at 37C and 5% CO2 in a humidified atmosphere. HEK293T SIRT7 knockout cells (SIRT7
/) were generated by
CRISPR/Cas9–mediated mutagenesis (Chen et al., 2016). HEK293T cells were transfected with lentiCRISPRv1 vectors harboring
single guide RNAs (sgRNAs 1-4) which target different regions within exon 1 of SIRT7. Single clones were retrieved after 7 dayse2 Cell Reports 25, 2946–2954.e1–e5, December 11, 2018
of puromycin selection (750 ng/mL), expanded and analyzed for SIRT7 expression by western blotting. Manifestation of the SIRT7
mutations was verified by PCR and sequencing.
METHOD DETAILS
Cell transfections and treatments
HEK293T cells were transfected with precipitates of plasmid DNA and calcium phosphate, and U2OS cells with Lipofectamine 3000
(ThermoFisher Scientific) and harvested after 30 h. siRNAs were transfected with Lipofectamine 2000 (ThermoFisher Scientific) and
cells were harvested after 48 h. For NOP58 knockdown, cells were transfected twice with siRNA and harvested after 96 h. HEK293T
and U2OS cells were arrested by treatment with 100 ng/mL nocodazole for 16 h. Bright-field imaging revealed that 90% of HEK293T
cells and 70%–80% of U2OS cells were arrested in mitosis. For immunofluorescence, U2OS cells were synchronized, fixed and
immunostained as described in the immunofluorescence method section. For rescue experiments, cells were first transfected
with siRNAs against the 30UTR of FBL or SIRT7 mRNA for 16-18 h followed by plasmid transfection and incubation for further
30 h. To inhibit KDACs and SIRT7, cells were treated for 5 hwith 1 mM trichostatin A (TSA) or 10mMnicotinamide (NAM), respectively.
Expression and purification of recombinant proteins
HEK293T cells expressing epitope-tagged proteins were lysed in buffer AM-300 (300mMKCl, 20mMTris-HCl [pH 7.9], 5mMMgCl2,
0.2 mM EDTA, 10% glycerol, 0.5 mM DTT) supplemented with 0.1% NP-40, protease inhibitors (Roche protease inhibitor cocktail,
100 mM phenylmethylsulfonyl fluoride (PMSF), and KDAC inhibitors (1 mM TSA, 5 mM sodium butyrate, 10 mM NAM). Lysates were
incubated at 4C for 4 h or overnight withmouse or rabbit IgGs (Dianova) bound to protein A/G-Sepharose (GEHealthcare) or withM2
anti-FLAG beads (Sigma-Aldrich) or with GFP-Trap (ChromoTek). After washing in lysis buffer, tagged proteins were eluted by boiling
in SDS sample buffer and analyzed on western blots. FLAG-tagged SIRT7 used in enzymatic assays was isolated from baculovirus-
infected Sf21 cells. Baculovirus-infected Sf21 cells were harvested 48 h post-infection. Lysis and immunoprecipitation was carried
out in AM-300/0.1% NP-40 buffer supplemented with protease inhibitors. FLAG-SIRT7 was eluted for 2 h at 4C in AM-300/20%
glycerol/0.1% NP-40 buffer containing 80 mg/mL FLAG-peptide (Sigma-Aldrich). Aliquots were flash-frozen in liquid nitrogen and
stored at 80C.
In vitro deacetylation assay
GFP-FBL co-expressed with HA-CBP in SIRT7/ cells was immobilized on GFP-Trap (ChromoTek) in AM-300 buffer (300 mM KCl,
20 mM Tris-HCl [pH 7.9], 5 mMMgCl2, 0.2 mM EDTA, 10% glycerol, 0.5 mM DTT) and incubated with FLAG-SIRT7 for 1 h at 30
C in
10 mM Tris-HCl [pH 8.0], 2 mMMgCl2, 10% glycerol, 0.2 mM DTT, 2.5 mM NAD
+. Acetylation was monitored on western blots using
anti-acetyl-lysine antibody.
Metabolic labeling of nascent RNA with 5-FUrd
U2OS cells grown on coverslips were labeled with 2 mM 5-fluorouridine (5-FUrd, Sigma-Aldrich) for 10 min, fixed with 1% parafor-
maldehyde for 10 min at room temperature, and permeabilized for 10 min on ice with 0.5% Triton X-100 in PBS. After blocking for
45 min with 3% BSA in PBS/0.2% Tween-20, the coverslips were incubated overnight at 4C with anti-BrdU (1:1000) and anti-
FBL (1:500) antibodies and stained with fluorophore-coupled secondary antibodies. DNA was stained with Hoechst 33342.
Metabolic labeling of RNA with 3H-uridine
Cells were cultured for 3 h in medium containing 5 mCi 3H-uridine (PerkinElmer). Cellular RNA (2 mg) was separated on denaturing 1%
agarose gels in 20 mM MOPS, [pH 7.0], 5 mM sodium acetate, 1 mM EDTA. After transfer to Hybond-N+ nylon membranes
(GE Healthcare), labeled RNA was visualized by fluorography using EN3HANCE (PerkinElmer).
Northern blotting
Cellular RNA (3-5 mg) was separated on MOPS-agarose gels, transferred to Hybond N+ nylon membranes (GE Healthcare) and hy-
bridized with 32P-labeled ITS1 oligonucleotide (Table S1) for 16 h at 45C in 6x SSC, 5x Denhardt’s buffer, 0.5% SDS and 100 mg/mL
yeast tRNA. After washing with 2x SSC/0.1% SDS and 1x SSC/0.1% SDS, radioactive signals were visualized by PhosphorImaging.
Crosslinked RNA immunoprecipitation (CLIP)
CLIP assays were performed as described (Chen et al., 2016). Briefly, nuclear lysates from UV-irradiated HEK293T cells (254 nm,
0.15 J/cm2) were sonicated, precleared with protein G Sepharose (GE Healthcare), and protein-RNA complexes were immunopre-
cipitated using anti-FLAG M2 beads or protein G Sepharose coated with mouse IgGs. Beads were washed twice with IP buffer
(20 mM Tris–HCl [pH 8.0], 200 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, protease
inhibitors) and twice with IP buffer containing 400mMKCl. After elution with the FLAG peptide (80 mg/mL) and proteinase K digestion
(30 min, 55C), RNA was isolated, incubated with DNase I (Sigma-Aldrich), reverse transcribed using random hexamers (Roche) and
MMLV reverse transcriptase (ThermoFisher Scientific), and subjected to RT-qPCR using primers listed in Table S1.Cell Reports 25, 2946–2954.e1–e5, December 11, 2018 e3
RiboMeth-seq
RiboMeth-seq analyses were performed according to a previously described protocol (Birkedal et al., 2015) in biological triplicates,
except nuclear RNA from HEK293T SIRT7/ cells, which was conducted in duplicates. In brief, cytoplasmic or nuclear RNA was
degraded by alkaline hydrolysis into short fragments. The 20-40 nt fraction was excised and purified from gels. Sequencing adaptors
were ligated to the fragments using a modified tRNA ligase and cDNA was synthesized using SuperScript IV reverse transcriptase
(ThermoFisher Scientific). Libraries were sequenced on an Ion Proton sequencer, mapped against the rDNA reference sequence
(Krogh et al., 2016), and scored for read-end counts. RiboMeth-seq scores (RMS) were calculated as previously described (‘‘score
C’’ in (Birkedal et al., 2015) and presented as mean ± standard deviations (mean ± SD). In a few cases (indicated in Table S2), a bar-
code correction was applied when calculating the RMS. We have noted that commercially purchased RNA adaptors can be hetero-
geneous in length. If the 30 adaptor is missing the first nucleotide at the 50 end and then ligated to a library fragment with the identical
nucleotide at its 30 end, the nucleotide from the library fragment will be removed in the sequence processing step intended to trim off
the adaptor sequence prior to mapping. Since libraries are made with different barcodes, such errors are easily detected and dealt
with by excluding the 30 read-end counts from the calculation at the affected site.
Immunofluorescence
U2OS cells grown on coverslips were fixed with 4% paraformaldehyde for 10 min at room temperature, permeabilized on ice for
10min with 0.5% Triton X-100 in PBS. For H2AQ104me staining, CSK buffer (10mMPIPES [pH 6.8], 100mMNaCl, 300mM sucrose,
3 mM MgCl2, 1 mM EGTA, and 0.5% Triton X-100) was used. After blocking in PBS containing 3% BSA and 0.2% Tween-20 for
45 min, cells were incubated overnight at 4C with the respective antibodies and stained with fluorophore-coupled secondary anti-
bodies. Images were visualized with a Zeiss microscope (Axiophot) using a 40A˚1.3 oil immersion Plan-Neofluar magnifying objec-
tive, captured with a device camera (DS-Qi1Mc; Nikon) and processed with NIS-Elements software (version BR 3.10; Nikon). Images
from at least three independent experiments were quantified using ImageJ software with at least 30-40 cells for each condition.
Protein pull-down experiments and co-immunoprecipitation
500 pmol of His-tagged histones H1 or H2A (purchased from Abcam) immobilized on 15 mL Ni-NTA agarose beads were incubated
with precleared nuclear lysates for 4 h at 4C in 50 mM NaH2PO4 [pH 7.9], 300 mM NaCl, 5 mM imidazole, 0.05% Tween-20 and
protease inhibitors (Roche Complete, PMSF). After washing in binding buffer, bead-bound proteins were analyzed by western blot-
ting. Uncoated Ni-NTA beads were used as background control. For pull-down assays, FLAG-tagged FBL or GFP-tagged SIRT7
were bound toM2-agarose or GFP-Trap in AM-buffer containing 150 mMKCl and proceeded as described in the protein purification
section. Immunoprecipitation of endogenous SIRT7 was performed as described above with 3 mg homemade anti-SIRT7 antibodies
(Chen et al., 2013). Immunoprecipitation with rabbit IgG served as negative control. Protein A-HRP (ThermoFischer Scientific) was
used for detection to reduce IgG background as heavy chain IgG (50 kDa) and endogenous SIRT7 (45 kDa) migrate very close
to each other.
Far-western blotting
FLAG-FBL was subjected to standard SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was blocked at
room temperature for 1 h in 5% skim milk in PBS/0.2% Tween-20. His-tagged histones H1 (ab206452) and H2A (ab200295) were
diluted to a final concentration of 75 nM and incubated with filter-bound FLAG-FBL in binding buffer (100 mM NaCl, 20 mM Tris
[pH 7.6], 0.5 mM EDTA, 10% glycerol, 0.1% Tween-20, 2% skim milk, 1 mM DTT) at 4C for 16 h. After washing in PBS/0.2%
Tween-20, anti-6X-His-tag (ab5000) antibody was used to detect bound histones and anti-FLAG antibody to monitor FLAG-FBL
which migrates at 37 kDa.
Duolink Proximity Ligation assay (PLA)
The Duolink PLA assay was performed according to the manufacturer’s instructions (Sigma-Aldrich). Briefly, U2OS cells were grown
on coverslips, fixed with 4% paraformaldehyde for 10 min at room temperature and permeabilized in PBS containing 0.5% Triton
X-100 for 15 min on ice. Cells were then blocked by incubation for 45 min in PBS with 3% BSA and 0.2% Tween-20 and incubated
with primary antibodies (mouse anti-FBL and rabbit anti-H2A). After incubation with oligonucleotide-labeled secondary antibodies
and ligation, DNA was amplified, hybridized to PLA probes and visualized by fluorescence microscopy.
Chromatin immunoprecipitation (ChIP)
Cells were fixed with 0.25% formaldehyde (10min, room temperature) and quenched with 125mMglycine for 5min. Cells were lysed
for 5 min in 5 mM HEPES [pH 8.0], 85 mM KCl and 0.5% NP-40. Nuclei were resuspended in 50 mM Tris-HCl [pH 8.1], 10 mM EDTA
[pH 8.0], 1%SDS and sonicated with a Bioruptor UCD-200 (Diagenode) to yield 250–500 bp DNA fragments. After 5-fold dilution with
0.01%SDS, 1.1%Triton X-100, 1.2mMEDTA, 16.7mMTris-HCl [pH 8.0], 167mMNaCl and preclearing with protein A/G Sepharose,
lysates were incubated overnight with the respective antibodies. Protein-DNA complexes were captured on protein A/G Sepharose
(GE Healthcare) blocked with 0.05% BSA and 200 mg/mL E. coli DNA. In case of FLAG-tagged FBL ChIPs, M2 agarose beads were
used to capture protein-DNA complexes overnight. Precipitates were washed in low salt buffer (150 mM NaCl, 50 mM Tris-HCl
[pH 8.0], 5 mM MgCl2, 1% Triton X-100), high salt buffer containing 500 mM NaCl, LiCl buffer (250 mM LiCl, 10 mM Tris-HCle4 Cell Reports 25, 2946–2954.e1–e5, December 11, 2018
[pH 8.0], 5 mMEDTA, 0.5%Na-deoxycholate, 0.5% Triton X-100) and TE buffer. Immunoprecipitates were eluted in 50 mMNaHCO3
solution containing 1% SDS. For FLAG ChIPs, immunoprecipitates were eluted for 4 h at 4C in AM-300/10% glycerol/0.1% NP-40
buffer containing 80 mg/mL FLAG peptide (Sigma-Aldrich). After decrosslinking and proteinase K digestion, DNA was purified and
analyzed by qPCR. Immunoprecipitated DNA was calculated as percentage of input DNA, after subtraction of background (IgG
values). The primers used for qPCR are listed in Table S1.
Formaldehyde-assisted identification of regulatory elements (FAIRE)
Chromatin accessibility was monitored by FAIRE assay. Briefly, cells were crosslinked with 0.25% formaldehyde for 10 min at room
temperature, quenched for 5min with 125mMglycine and lysed in FAIRE buffer 1 (50mMHEPES-KOH [pH 7.5], 140mMNaCl, 1mM
EDTA, 10% glycerol, 0.5%NP-40, 0.25% Triton X-100) at 4C for 10min. Nuclei were spun down (5,000 rpm, 5min) and incubated in
FAIRE buffer 2 (10 mM Tris-HCl [pH 8.0], 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA) for 10 min at room temperature. After an
additional spin, sedimented chromatin was sheared in FAIRE buffer 3 (10 mM Tris-HCl, [pH 8.0], 100 mM NaCl, 1 mM EDTA,
0.5 mM EGTA, 0.1% sodium deoxycholate, 0.5% N-lauroylsarcosine) to an average length of 200-400 bp. Samples were cleared
by centrifugation, 10% of the supernatants were removed as input and the rest was extracted twice with phenol/chloroform and
once with chloroform. Input and extracted DNA were decrosslinked by incubation at 65C for 16 h and purified with the QIAquick
PCR purification kit (QIAGEN) followed by qPCR analysis.
Flow Cytometry
Approximately 1x106 cells were fixed with ice-cold 70% ethanol and stored at 20C for at least 3 h. Fixed cells were washed with
PBS and stainedwith propidium iodide for 30min in the presence of RNase A. Cells were analyzed on aMUSE flow cytometer (Merck)
according to the manufacturer’s protocol.
Histone extraction
HEK293T cells were harvested in PBS, washed, lysed in PBS containing 0.5% Triton X-100 and isolated nuclei were incubated in
0.2 N HCl at 4C overnight. Extracts were cleared by centrifugation and neutralized with 0.1 volume of 1 M Tris base (Sigma-Aldrich).
For western blotting, 2 mg of histones were loaded on 15% SDS polyacrylamide gels.
QUANTIFICATION AND STATISTICAL ANALYSIS
The values in the graphs show means of at least three independent experiments with error bars representing standard error of mean
(SEM) unless otherwise specified. Data indicate representative immunofluorescence images of at least three independent experi-
ments which were analyzed with at least 30-40 cells for each condition. In qPCR experiments, the two groups were compared using
a paired two-tailed Student’s t test. Column scatter-dot plots representing quantification of immunofluorescence images were drawn
using Graphpad Prism. Unpaired two-tailed Student’s t test with Welch’s correction was used to calculate p values. The significance
level was set at *p% 0.05 or **p% 0.01 or ***p% 0.001. Ratio of FBL acetylation to FBL loading in western blots and H2A bound to
immobilized FBL in Far-western experiments was quantified by densitometric analysis using ImageJ software. In each case the ratios
were normalized to the control conditions (lane 1) within the given experiment. In the RiboMeth-seq analysis, error bars indicate
standard deviation (SD) and significance was calculated using unpaired Student’s t test for 20-O-Me sites with a difference in
mean RMS > 0.05. *p% 0.05, **p% 0.01.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RiboMeth-seq data reported in this paper is NCBI Gene Expression Omnibus: GSE115360.Cell Reports 25, 2946–2954.e1–e5, December 11, 2018 e5
